Intervention Review

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

  1. Gillian E Mead1,*,
  2. Cheng-Fang Hsieh2,
  3. Rebecca Lee3,
  4. Mansur A Kutlubaev4,
  5. Anne Claxton5,
  6. Graeme J Hankey5,
  7. Maree L Hackett6

Editorial Group: Cochrane Stroke Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 10 JUL 2012

DOI: 10.1002/14651858.CD009286.pub2


How to Cite

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009286. DOI: 10.1002/14651858.CD009286.pub2.

Author Information

  1. 1

    University of Edinburgh, Centre for Clinical Brain Sciences, Edinburgh, UK

  2. 2

    Kaohsiung Medical University Hospital, Division of Geriatrics and Gerontology, Department of Internal Medicine and Department of Neurology, Kaohsiung, Taiwan

  3. 3

    Western General Hospital, Department of Medicine of the Elderly, Edinburgh, UK

  4. 4

    Western General Hospital, Division of Clinical Neurosciences, Edinburgh, UK

  5. 5

    Royal Perth Hospital, Department of Neurology, Perth, Western Australia, Australia

  6. 6

    The George Institute for Global Health, Department of Neurological and Mental Health, Sydney, NSW, Australia

*Gillian E Mead, Centre for Clinical Brain Sciences, University of Edinburgh, Room S1642, Royal Infirmary, Little France Crescent, Edinburgh, EH16 4SA, UK. gillian.e.mead@ed.ac.uk. gmead@staffmail.ed.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dirk K. Wolter, Depressionen im höheren Lebensalter, Teil 2, Zeitschrift für Gerontologie und Geriatrie, 2016,

    CrossRef

  2. 2
    Christodouli Lagogianni, Shirley Thomas, Nadina Lincoln, Examining the relationship between fatigue and cognition after stroke: A systematic review, Neuropsychological Rehabilitation, 2016, 1

    CrossRef

  3. 3
    Bruce H. Dobkin, Stroke, 2016,

    CrossRef

  4. 4
    Toby B. Cumming, Christian Blomstrand, Ingmar Skoog, Thomas Linden, The High Prevalence of Anxiety Disorders After Stroke, The American Journal of Geriatric Psychiatry, 2015,

    CrossRef

  5. 5
    Ivan Rektor, Steven C. Schachter, Ravindra Arya, Shahar Arzy, Hilde Braakman, Martin J. Brodie, Peter Brugger, Bernard S. Chang, Alla Guekht, Bruce Hermann, Dale C. Hesdorffer, Marilyn Jones-Gotman, Andres M. Kanner, Luis Garcia-Larrea, Pavel Mareš, Marco Mula, Miri Neufeld, Gail L. Risse, Philippe Ryvlin, Margitta Seeck, Torbjörn Tomson, Amos D. Korczyn, Third International Congress on Epilepsy, Brain, and Mind: Part 2, Epilepsy & Behavior, 2015, 50, 138

    CrossRef

  6. 6
    Hsiao-Ting Juang, Pei-Chun Chen, Kuo-Liong Chien, Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study, BMC Neurology, 2015, 15, 1

    CrossRef

  7. 7
    Reza Bagherpour, Dennis D. Dykstra, A. M. Barrett, Andreas R. Luft, Afshin A. Divani, A Comprehensive Neurorehabilitation Program Should be an Integral Part of a Comprehensive Stroke Center, Frontiers in Neurology, 2014, 5,

    CrossRef

  8. 8
    Matildes F. M. Sobreiro, Eliane Correa Miotto, Luisa Terroni, Gisela Tinone, Dan V. Iosifescu, Mara C. S. de Lucia, Milberto Scaff, Claudia da Costa Leite, Edson Amaro, Renerio Fraguas, Executive function and depressive symptoms of retardation in nonelderly stroke patients, Journal of Clinical and Experimental Neuropsychology, 2014, 36, 6, 636

    CrossRef

  9. 9
    L. Ayerbe, S. A. Ayis, S. Crichton, C. D. A. Wolfe, A. G. Rudd, Natural history, predictors and associated outcomes of anxiety up to 10 years after stroke: the South London Stroke Register, Age and Ageing, 2014, 43, 4, 542

    CrossRef

  10. 10
    Robert J. Boland, Kristina G. Gaud, Martin B. Keller, Antidepressants,
  11. 11
    William Cayley Jr, Do selective serotonin reuptake inhibitors (SSRI) improve outcomes in people recovering from a stroke?, Cochrane Clinical Answers,